Der Internist

, Volume 54, Issue 12, pp 1520–1522 | Cite as

Kardiovaskuläre Auswirkungen hormoneller Kontrazeption

Klinische Studien

Cardiovascular effects of hormonal contraception

Literatur

  1. 1.
    Lidegaard Ø, Nielsen LH, Skovlund CW, Lokkegaard E (2012) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 344:e2990PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Lidegaard Ø, Nielsen LH, Skovlund CW et al (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 343:d6423PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Severinsen MT, Kristensen SR, Overvad K et al (2010) Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 63:223–228Google Scholar
  4. 4.
    Sherif K (1999) Benefits and risks of oral contraceptives. Am J Obstet Gynecol 180(6 Suppl):S343–S348PubMedCrossRefGoogle Scholar
  5. 5.
    Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Zentrum für Epidemiologie und Gesundheitsforschung BerlinBerlinDeutschland
  2. 2.Werl-WestönnenDeutschland

Personalised recommendations